Working to Eradicate Gynecologic Cancers

Ruby Meredith, MD

Professor
University of Alabama at Birmingham
1720 2nd Ave S
Birmingham, AL
USA 35233

Papers:
157 Long term safety follow up, dosimetry and immunologic responses in patients enrolled on a phase I trial of intraperitoneal 212Pb labeled trastuzumab